Comparative Pharmacology
Head-to-head clinical analysis: CHILDREN S MOTRIN versus CLINORIL.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CHILDREN S MOTRIN versus CLINORIL.
CHILDREN'S MOTRIN vs CLINORIL
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX-1 and COX-2), reducing prostaglandin synthesis, thereby decreasing pain, fever, and inflammation.
Nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX-1 and COX-2), reducing prostaglandin synthesis, thereby exerting anti-inflammatory, analgesic, and antipyretic effects. Sulindac is a prodrug converted to the active sulfide metabolite.
200-400 mg orally every 6-8 hours as needed; maximum 1200 mg/day without prescription, extended release forms: 600-800 mg orally twice daily.
150-200 mg orally twice daily, with maximum daily dose of 400 mg.
None Documented
None Documented
2-4 hours in children; prolonged in neonates and hepatic impairment.
7.8 hours (terminal); clinical context: prolonged in elderly and renal impairment, requiring dose adjustment.
Renal (90%) as inactive metabolites and conjugates; fecal (<5%).
Renal: 50% as unchanged drug, 25% as glucuronide conjugate; Biliary/Fecal: 25% as metabolites.
Category C
Category C
NSAID
NSAID